Medications & Supplements/Prescription Drugs

Lisinopril 10 mg Tablets Recalled for Metal Fragment Contamination

Agency Publication Date: September 15, 2022

Summary

RemedyRepack Inc. is recalling 1,699 blister cards of Lisinopril (10 mg), a prescription medication used to treat high blood pressure. The recall was issued after a metal fragment was found embedded in one tablet. No injuries or adverse events have been reported to date.

Risk

Ingesting a tablet with a foreign metal fragment could cause physical injury to the mouth, throat, or digestive system.

What You Should Do

This recall affects Lisinopril 10 mg tablets (30-count blister cards) repackaged by RemedyRepack Inc. with NDC 70518-0468-00, which were originally manufactured by Lupin Pharma (NDC 68180-0980-03).
Check your medication packaging for lot numbers J0636336-073022 or J0637605-080422, both with an expiration date of 08/31/2023.
If you have health concerns, contact your healthcare provider or pharmacist. Return any unused product to the place of purchase for a refund, throw it away, or contact RemedyRepack Inc. for further instructions.
Call the FDA Consumer Complaint hotline at 1-888-723-3332 (1-888-SAFEFDA) for additional questions regarding this recall.

Your Remedy Options

You have 2 options:

Option 1: Full Refund

How to: Contact your healthcare provider or pharmacist for guidance, or return any unused product to the place of purchase for a refund

Option 2: Dispose of Product

How to: Throw the product away. For prescription medications, a DEA take-back location or pharmacy mail-back program is preferred when available.

Affected Products

Product: Lisinopril Tablets (10 mg)

Variants: 10 mg, 30-count Blister Card, Tablet

Lot Numbers:

J0636336-073022 (Exp 08/31/2023)

J0637605-080422 (Exp 08/31/2023)

NDC:

70518-0468-00

68180-0980-03

Repackaged by RemedyRepack Inc. from original manufacturer Lupin Pharma.

Additional Information

Agency: Food and Drug Administration (FDA)

Event ID: 90873

Status: Resolved

Manufacturer: RemedyRepack Inc.

Sold By: direct accounts

Manufactured In: United States

Units Affected: 1,699 blister cards/30 tablets each

Distributed To: Pennsylvania, Alaska

Were You Affected by This Recall?

If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.

Find an Attorney

This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.

AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.

Sources: FDA iRES · Raw API Response

openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.

What You Should Do

This recall affects Lisinopril 10 mg tablets (30-count blister cards) repackaged by RemedyRepack Inc. with NDC 70518-0468-00, which were originally manufactured by Lupin Pharma (NDC 68180-0980-03).

Check your medication packaging for lot numbers J0636336-073022 or J0637605-080422, both with an expiration date of 08/31/2023.

If you have health concerns, contact your healthcare provider or pharmacist. Return any unused product to the place of purchase for a refund, throw it away, or contact RemedyRepack Inc. for further instructions.

Call the FDA Consumer Complaint hotline at 1-888-723-3332 (1-888-SAFEFDA) for additional questions regarding this recall.